共 29 条
- [1] Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of REnal and vascular ENdstage disease (PREVEND) study and the prevention of REnal and vascular ENdstage disease intervention trial (PREVEND IT) [J]. CLINICAL THERAPEUTICS, 2006, 28 (03) : 432 - 444
- [2] Screening for proteinuria in US adults - A cost-effectiveness analysis [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3101 - 3114
- [4] Urinary albumin excretion as a predictor of the development of hypertension in the general population [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02): : 331 - 335
- [8] Prevalence of chronic kidney disease in the United States [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17): : 2038 - 2047
- [9] Screening for chronic kidney disease: Where does Europe go? [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (02): : 616 - 623
- [10] Screening, monitoring, and treatment of albuminuria: Public health perspectives [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08): : 2120 - 2126